The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib clinical trial on intratumoral administration of autologous CD1c (BDCA-1)+ myeloid dendritic cells (myDC) in combination with ipilimumab (IPI) and avelumab (AVE) plus intravenous low-dose nivolumab (NIVO) in patients with advanced solid tumors.
 
Julia Katharina Schwarze
Travel, Accommodations, Expenses - MSD travel grant
 
Gil Awada
Travel, Accommodations, Expenses - MSD travel grant
 
Louise Cras
No Relationships to Disclose
 
Ramses Forsyth
No Relationships to Disclose
 
Ivan Van Riet
No Relationships to Disclose
 
Bart Neyns
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Etherna; Merck Sharp & Dohme; Novartis; Pfizer/EMD Serono; Roche; Sanofi
Speakers' Bureau - Novartis
Research Funding - Merck KGaA (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche